Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis
Table 2
Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Summary of findings table for the comparison remdesivir 10 days vs. placebo for hospitalized, severe COVID-19.